Luye Considering $500 Million IPO for Healthcare Assets

Luye Medical, the healthcare arm of Luye Life Sciences, is considering an IPO in Singapore that could raise as much as $500 million. The company has assembled a portfolio of businesses, largely through M&A, consisting of hospitals, clinics and diagnostic services that spreads across China , Australia and Singapore . It is based in Singapore. Luye Pharma, which is also part of Luye Life Sciences, is the parent's listed pharmaceutical subsidiary. More details.... Stock Symbol: (HK: 2186) Share this with colleagues: // //